<DOC>
	<DOCNO>NCT00987272</DOCNO>
	<brief_summary>The purpose study demonstrate safety efficacy Olopatadine 0.2 % compare vehicle Japanese subject treatment acute allergen-mediated conjunctivitis use conjunctival allergen challenge ( CAC ) test .</brief_summary>
	<brief_title>Study Olopatadine HCl Ophthalmic Solutions Compared Vehicle Using Conjunctival Allergen Challenge ( CAC ) Model Acute Allergic Conjunctivitis Japanese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Japanese ethnicity . Seasonal Allergic Conjunctivitisasymptomatic . Other protocoldefined inclusion criterion may apply . Manifest sign symptom clinically active allergic conjunctivitis either eye ( &gt; 1 redness 3 vessel bed conjunctival , episcleral , ciliary itching &gt; 0 ) start visit . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Allergies</keyword>
	<keyword>Ocular</keyword>
</DOC>